Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
December 8, 2025BloodOpen Access

Targeting ephrin A3 in the bone marrow niche offers a promising therapeutic strategy to impede hematopoietic stem cell maintenance in MDS patients

View Full Paper
Ask AI
Bookmark
Share

Authors

MGMarie GoulardRGRemisha GurungLALinda Ariza-McNaughton

Discussion

Loading...

Member takes

Overview

Analysis reveals targeting hematopoietic stem cell interactions in bone marrow niche may improve outcomes in myelodysplastic syndrome.

Key Points

  • Apoptosis of mesenchymal stromal cells potentially disrupts maintenance of hematopoietic stem cells in MDS.
  • Single-cell RNA sequencing showed disease-like transcriptomic profiles of MDS HSPCs under specific conditions.
  • Therapeutic target EPHA3 exhibited significant interactions controlled by IL10 from MDS HSPCs, revealing new pathways.
  • Bone marrow niche interactions may accelerate myelodysplastic syndrome progression and offer selective intervention opportunities.

Cite This Study

Goulard et al. (2025) studied this question.

synapsesocial.com/papers/69362f514fa91c937236d977https://doi.org/10.1182/blood-2025-859
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Human bone scaffolds support clonal persistence and functional retention of MDS-derived CD34+ cells in a 3D in vitro bone marrow model2025
  2. 2Sf3b1+/K700E hematopoietic stem cells create their own expansion niche2025
  3. 3Bone marrow immune and stromal niche remodeling in myelodysplastic neoplasm patients under erythropoietic therapies by 29-color full-spectrum flow cytometry2025
  4. 4Title: Hacs1 is a myeloma immunosuppressor driving pro-tumorigenic myelopoiesis and myeloid cell differentiation through MS4A3/IL3/GM-CSF signaling2025
  5. 5Molecular signature and regulatory network of human umbilical cord mesenchymal stromal cells as a niche for hematopoietic stem cells and progenitors2025